Latest News for: cah
Edit
CAHS Scholarly Showcase 2026 highlights record student participation and expanded opportunities (University of Cincinnati)
Public Technologies 20 Apr 2026
) CAHS Scholarly Showcase 2026 highlights record student participation and expanded opportunities ... The 2026 CAHS Scholarly Showcase was held in the Health Sciences Building on the university's medical campus.
Edit
CAH Celebrates 40 Years of the Art Bank Program and Announces 2026 Grant Cycle (District of Columbia Commission on the Arts and Humanities)
Public Technologies 08 Apr 2026
Edit
Community Action House announces grand opening for new resale store
Holland Sentinel 08 Apr 2026
Edit
Spaghetti, History, and Community: CAHS Dinner Returns April 13
The Sun Times News 30 Mar 2026
The Chelsea Area Historical Society (CAHS) will host its annual Lynda ...
Edit
Why Is Cardinal Health (CAH) Stock Rocketing Higher Today
The Call 05 Feb 2026
What Happened? ... CAH) jumped 10.1% in the afternoon session after the company reported better-than-expected fourth-quarter financial results and raised its full-year earnings guidance ... Click here to access our full research report, it’s free. More News ... .
Edit
Cardinal Health (NYSE:CAH) Exceeds Q4 CY2025 Expectations
The Call 05 Feb 2026
CAH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 18.8% year on year to $65.63 billion ... Cardinal Health (CAH) Q4 CY2025 Highlights. ... CAH) distributes ...
Edit
What To Expect From Cardinal Health’s (CAH) Q4 Earnings
The Call 04 Feb 2026
Healthcare distributor and services company Cardinal Health (NYSE. CAH) will be reporting results this Thursday before the bell. Here’s what to expect ... Adjusted earnings are expected to come in at $2.37 per share ... More News. View More ... Via MarketBeat ... .
Edit
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Nasdaq Globe Newswire 22 Jan 2026
Edit
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH) (Crinetics Pharmaceuticals Inc)
Public Technologies 22 Jan 2026
First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and adolescents with classic CAH ... Food & Drug Administration for atumelnant in the treatment of classic CAH.
- 1